Mechanisms of the relaxant effect of a Danshen and Gegen formulation on rat isolated cerebral basilar artery

Journal of Ethnopharmacology

Volumn 132, Issue 1, 2010, Pages 186-192

  Lam, F F Y ^a   Deng, S Y ^a   Ng, E S K ^a   Yeung, J H K ^a   Kwan, Y W ^a   Lau, C B S ^b   Koon, J C M ^b   Zhou, L ^a   Zuo, Z ^a   Leung, P C ^b   Fung, K P ^a,b  

^a Chinese University of Hong Kong   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cerebral basilar artery; Danshen; Gegen

Indexed keywords

4 AMINOPYRIDINE; BARIUM CHLORIDE; CALCIUM CHANNEL; GLIBENCLAMIDE; HERBACEOUS AGENT; IBERIOTOXIN; POTASSIUM CHANNEL; PUERARIA LOBATA EXTRACT PLUS SALVIA MILTIORRHIZA EXTRACT; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BASILAR ARTERY; CALCIUM TRANSPORT; CHINESE MEDICINE; DRUG MECHANISM; IC 50; MALE; MEDICINAL PLANT; NONHUMAN; PUERARIA LOBATA; RAT; VASODILATATION;

PUERARIA MONTANA VAR. LOBATA; RATTUS; SALVIA MILTIORRHIZA;

EID: 77957764454     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.08.015     Document Type: Article

References (44)

1. Adams J.D., Wang R., Yang J., Lien E.J. Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chinese Medicine 2006, 1:3.
2. Bilginer B., Onal B., Yigitkanli K., Soylemezoglu F., Bavbek M., Ziyal I.M., Ozgen T. Treatment of cerebral vasospasm with cilostazol in subaracinoid haemorrhage model. Acta Neurochirurgica Supplementary 2008, 104:291-296.
3. Cao C.M., Xia Q., Zhang X., Xu W.H., Jiang H.D., Chen J.Z. Salvia miltiorrhiza attenuates the changes in contraction and intracellular calcium induced by anoxia and reoxygenation in rat cardiomyocytes. Life Sciences 2003, 72:2451-2463.
4. Cao Z.L., Li J.P., Zhang D.M. Advances in the studies of isflavonoids in medicinal plants of Pueraria species. Zhong Yao Cai 2005, 28:67-71.
5. Chan Y.L., Woo K.S., Leung P.C., Fung K.P. Traditional Chinese medicine Danshen-Gegen combination formula improves atherogenic pathophysiology: an in-vitro and ex-vivo study. Journal of the Hong Kong College of Cardiology 2006, 14:28.
6. Chan K., Chui S.H., Wong D.Y., Ha W.Y., Chan C.L., Wong R.N. Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction. Life Sciences 2004, 75:3157-3171.
7. Chang Q., Sun L., Zhao R.H., Chow M.S.S., Zuo Z. Simultaneous determination of ten active components in traditional Chinese medicinal products containing both gegen (Pueraria lobata) and Danshen (Salvia miltiorrhiza) by high-performance liquid chromatography. Phytochemical Analysis 2008, 19:368-375.
8. Chen Y.M. A clinical practice of Jiang-Zhi-Yin on therapeutic effects of lipid disorder. Zhonghua Yixue Zazhi 2002, 2:1020-1021.
9. Cheng, Y.Y., Fong, S.M., Chang, H.M., 1990. Protective action of Salvia miltiorrhiza aqueous extract on chemically induced acute myocardial ischemia in rats. Chinese Journal of Modern Developments in Traditional Medicine/Zhongguo Zhong Xi Yi Jjie He Yan Jiu Hui (Chou), Zhong Yi Yan Jiu Yuan, Zhu Ban 10, 609-611, 582.
10. Choi H.S., Kim K.M. Tanshinones inhibit mast cell degranulation by interfering with IgE receptor-mediated tyrosine phosphorylation of PLCgamma2 and MAPK. Planta Medica 2004, 70:178-180.
11. Choo M.K., Park E.K., Yoon H.K., Kim D.H. Antithrombotic and antiallergic activities of Daidzein, a metabolite of puerarin and daidzin produced by human intestinal microflora. Biological and Pharmaceutical Bulletin 2002, 25:1328-1332.
12. Cui S.K., Li G.H. Clinical effect of Fufang Danshen Dripping Pill on hyperlipemia. Xiandai Zhongxiyi Jiehe Zazhi 2003, 11:1029-1030.
13. Godfraind T., Miller R., Wibo M. Calcium antagonism and calcium entry blockade. Pharmacological Reviews 1986, 38:321-416.
14. Hintz K.K., Ren J. Phytoestrogenic isoflavones daidzein and genistein reduce glucose-toxicity-induced cardiac contractile dysfunction in ventricular myocytes. Endocrine Research 2004, 30:215-223.
15. 2+ channels in the rat aorta. The Chinese Journal of Physiology 1996, 39:1-8.
16. Ji X.Y., Tan B.K., Zhu Y.Z. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacologica Sinica 2000, 21:1089-1094.
17. Kamata K., Iizuka T., Nagai M., Kasuya Y. Endothelium-dependent vasodilator effects of the extract from Salviae Miltiorrhizae radix. A study on the identification of lithospermic acid B in the extracts. General Pharmacology 1993, 24:977-981.
18. Kang B.Y., Chung S.W., Kim S.H., Ryu S.Y., Kim T.S. Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhiza. Immunopharmacology 2000, 49:355-361.
19. Kohda H., Takeda O., Tanaka S., Yamasaki K., Yamashita A., Kurokawa T., Ishibashi S. Isolation of inhibitors of adenylate cyclase from dan-shen, the root of Salvia miltiorrhiza. Chemical & Pharmaceutical Bulletin 1989, 37:1287-1290.
20. Ca channels by salvianolic acid B of the porcine coronary artery smooth muscle cells. European Journal of Pharmacology 2006, 546:28-35.
21. Lam F.F.Y., Yeung J.H.K., Chan K.M., Or P.M.Y. Relaxant effects of danshen aqueous extract and its constituent danshensu on rat coronary artery are mediated by inhibition of calcium channels. Vascular Pharmacology 2007, 46:271-277.
22. Lam F.F.Y., Yeung J.H.K., Chan K.M., Or P.M.Y. Mechanisms of the dilator action of cryptotanshinone on rat coronary artery. European Journal of Pharmacology 2008, 578:253-260.
23. Lam F.F.Y., Yeung J.H.K., Chan K.M., Or P.M.Y. Dihydrotanshinone, a lipophilic component of Salvia miltiorrhiiza (danshen), relazes rat coronary artery by inhibition of calcium channels. Journal of Ethnopharmacology 2008, 119:318-321.
24. Lam F.F.Y, Yeung J.H.K., Kwan Y.W., Chan K.M., Or P.M.Y. Salvianolic acid B, an aqueous component of danshen (Salvia miltiorrhiza), relaxes rat coronary artery by inhibition of calcium channels. European Journal of Pharmacology 2006, 553:240-245.
25. Lam H.M., Yam W.S., Lau K.M., Leung L.K., Koon C.M., Woo K.S., Huang Y., Waye M.Y., Fung K.P. Antioxidative and vasodilative effects of danshen and gegen. Journal of Molecular and Cellular Cardiology 2005, 38:840.
26. Lee D.S., Lee S.H., Noh J.G., Hong S.D. Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza Bunge. Bioscience, Biotechnology, and Biochemistry 1999, 63:2236-2239.
27. Lei X.L., Chiou G.C. Studies on cardiovascular actions of Salvia miltiorrhiza. The American Journal of Chinese Medicine 1986, 14:26-32.
28. Li C.P., Yung K.H., Chiu K.W. Hypotensive action of Salvia miltiorrhiza cell culture extract. The American Journal of Chinese Medicine 1990, 18:157-166.
29. Li Z.T., Yang B.J., Ma G.E. Chemical studies of Salvia miltiorrhiza f. alba. Acta Pharmaceutica Sinica 1991, 26:209-213.
30. Liu G.T., Zhang T.M., Wang B.E., Wang Y.W. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochemical Pharmacology 1992, 43:147-152.
31. Liu Q., Wang L., Lu Z., Xiong Y. Effect of puerarin on coronary collateral circulation in dogs with experimental acute myocardial infarction. Zhongguo Zhong Yao Za Zhi 1999, 24:304-306.
32. Mosaddik M.A. In vitro cytotoxicity of tanshinones isolated from Salvia miltiorrhiza Bunge against P388 lymphocytic leukemia cells. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 2003, 10:682-685.
33. Pluta R.M. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacology and Therapeutics 2005, 101:23-56.
34. Ren J.S., Luo X.H. A review on the combination uses of Gegen and Danshen in traditional Chinese medicine. Shanxi Zhongyi Xueyuan Xuebao 2006, 7:51-52.
35. Si J., Chang Q., Shen L., Chen D. Chemical constituents from Pueraria lobata. Journal of Chinese Pharmaceutical Sciences 2006, 15:248-250.
36. Sieveking D.P., Woo K.S., Fung K.P., Lundman P., Nakhla S., Celermajer D.S. Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro. International Journal of Cardiology 2005, 105:40-45.
37. Song X.P., Chen P.P., Chai X.S. Effects of puerarin on blood pressure and plasma rennin activity in spontaneously hypertensive rats. Acta Pharmacologica Sinica 1988, 9:55-58.
38. Tam L.W.Y., Chook P., Poon P.Y.K., Qiao M., Chan L.L.T., Cheung A.S.P., Chan T.Y.K., Fung K.P., Tang K.S.L., Lau V.K.M., Koon J.C.M., Leung P.C., Celemajer D.S., Woo K.S. Danshen and Gegen as cardiovascular tonic in coronary patients: a novel strategy for secondary atherosclerosis prevention. Journal of the Hong Kong College of Cardiology 2004, 12:32.
39. Xu J.K., Hiroshi K., Zheng J.J., Jiang T., Yao X.S. Protective effect of tanshinones against liver injury in mice loaded with restraint stress. Acta Pharmaceutica Sinica 2006, 41:631-635.
40. Yan L.P., Chan S.W., Chan A.S.C., Chen S.L., Ma X.J., Xu H.X. Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sciences 2006, 79:324-330.
41. + channels in vascular smooth muscle cells. European Journal of Pharmacology 2010, 630:100-106.
42. Zhang J., Huang M., Guan S., Bi H.C., Pan Y., Duan W., Chan S.Y., Chen X., Hong Y.H., Bian J.S., Yang H.Y., Zhou S. A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza. The Journal of Pharmacology and Experimental Therapeutics 2006, 317:1285-1294.
43. Zhang R.G., Liu F.M. Advances in the studies on cardiovascular effects of Pueraria species. Zhong Yao Cai 2001, 24:535-536.
44. Zhang W.X., Ma D.L., Zhang Y., Gao Y. The studies on the stability of a Chinese medicine Guan-Xin tablet. Zhongguo Zhongyao Zazhi 1991, 16:284-285.